7 research outputs found

    Representative picture of the experimental set up.

    No full text
    <p>The participant is performing a squat exercise in the condition currently adopted for healthy subjects in fitness centers.</p

    Luminescence of Eu<sup>3+</sup> Activated CaF<sub>2</sub> and SrF<sub>2</sub> Nanoparticles: Effect of the Particle Size and Codoping with Alkaline Ions

    No full text
    Eu<sup>3+</sup> doped CaF<sub>2</sub> and SrF<sub>2</sub> nanoparticles were synthesized through a facile hydrothermal technique, using citrate ions as capping agents and Na<sup>+</sup> or K<sup>+</sup> as charge compensator ions. A proper tuning of the reaction time can modulate the nanoparticle size, from few to several tens of nanometers. Analysis of EXAFS spectra indicate that the Eu<sup>3+</sup> ions enter into the fluorite CaF<sub>2</sub> and SrF<sub>2</sub> structure as substitutional defects on the metal site. Laser site selective spectroscopy demonstrates that the Eu<sup>3+</sup> ions are mainly accommodated in two sites with different symmetries. The relative site distribution for lanthanide ions depends on the nanoparticle size, and higher symmetry Eu<sup>3+</sup> sites are prevalent for bigger nanoparticles. Eu<sup>3+</sup> ions in high symmetry sites present lifetimes of the <sup>5</sup>D<sub>0</sub> level around 27 ms, among the longest lifetimes found in the literature for Eu<sup>3+</sup> activated materials. As a proof of concept of possible use of the Eu<sup>3+</sup> activated alkaline-earth fluoride nanoparticles in nanomedicine, the red luminescence generated by two-photon absorption using pulsed laser excitation at 790 nm (in the first biological window) has been detected. The long Eu<sup>3+</sup> lifetimes suggest that the present nanomaterials can be interesting as luminescent probes in time-resolved fluorescence techniques in biomedical imaging (e.g., FLIM) where fast autofluorescence is a drawback to avoid

    Inhibition of <i>Pseudomonas aeruginosa</i> secreted virulence factors reduces lung inflammation in CF mice

    No full text
    <p><b>Background</b>: Cystic fibrosis (CF) lung infection is a complex condition where opportunistic pathogens and defective immune system cooperate in developing a constant cycle of infection and inflammation. The major pathogen, <i>Pseudomonas aeruginosa</i>, secretes a multitude of virulence factors involved in host immune response and lung tissue damage. In this study, we examined the possible anti-inflammatory effects of molecules inhibiting <i>P. aeruginosa</i> virulence factors.</p> <p><b>Methods</b>: Pyocyanin, pyoverdine and proteases were measured in bacterial culture supernatant from different <i>P. aeruginosa</i> strains. Inhibition of virulence factors by sub-inhibitory concentrations of clarithromycin and by protease inhibitors was evaluated. Lung inflammatory response was monitored by in vivo bioluminescence imaging in wild-type and CFTR-knockout mice expressing a luciferase gene under the control of a bovine IL-8 promoter.</p> <p><b>Results</b>: The amount of proteases, pyocyanin and pyoverdine secreted by P. aeruginosa strains was reduced after growth in the presence of a sub-inhibitory dose of clarithromycin. Intratracheal challenge with culture supernatant containing bacteria-released products induced a strong IL-8-mediated response in mouse lungs while lack of virulence factors corresponded to a reduction in bioluminescence emission. Particularly, sole inactivation of proteases by inhibitors Ilomastat and Marimastat also resulted in decreased lung inflammation.</p> <p><b>Conclusions</b>: Our data support the assumption that virulence factors are involved in <i>P. aeruginosa</i> pro-inflammatory action in CF lungs; particularly, proteases seem to play an important role. Inhibition of virulence factors production and activity resulted in decreased lung inflammation; thus, clarithromycin and protease inhibitors potentially represent additional therapeutic therapies for <i>P. aeruginosa</i>-infected patients.</p

    MOESM1 of In vivo monitoring of lung inflammation in CFTR-deficient mice

    No full text
    Additional file 1: Figure S1. In vivo bioluminescence imaging. Monitoring bIL-8 activation in WT and CF transiently transgenized mice with bIL-8-Luc plasmid at 3, 4 and 7 days after DNA delivery. Results are reported photons/sec/cm2 as mean ± SEM, n = 6 each group. Statistical differences were tested by one-way ANOVA followed by Dunnett’s t post hoc test for group comparisons. *p < 0.05 and **p < 0.01
    corecore